Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Dow
McKesson
Fuji
Express Scripts
AstraZeneca
Chubb
Citi

Generated: May 25, 2018

DrugPatentWatch Database Preview

TASMAR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Tasmar patents expire, and when can generic versions of Tasmar launch?

Tasmar is a drug marketed by Valeant Pharms Llc and is included in one NDA.

The generic ingredient in TASMAR is tolcapone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tolcapone profile page.
Drug patent expirations by year for TASMAR
Pharmacology for TASMAR
Synonyms for TASMAR
(3,4-dihydroxy-5-nitro-phenyl)-(p-tolyl)methanone
(3,4-Dihydroxy-5-nitro-phenyl)-p-tolyl-methanone
(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone
(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-methanon
(3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone
(3,4-dihydroxy-5-nitrophenyl)(p-tolyl)methanone
134308-13-7
3,4-dihydroxy-4 inverted exclamation mark -methyl-5-nitrobenzophenone
3,4-Dihydroxy-4?-methyl-5-nitrobenzophenone
3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone
3,4-dihydroxy-5-nitro-4'-methylbenzophenone
3,4-dihydroxy-5'-methyl-5-nitrobenzophenone
3,4-dihydroxyl-5-nitrobenzyl,4'-methylbenzenyl ketone
308T137
3s68
4'-methyl-3,4-dihydroxy-5-nitrobenzophenone
5-(4-methylbenzoyl)-3-nitrobenzene-1,2-diol
5-[(4-METHYLPHENYL)CARBONYL]-3-NITROBENZENE-1,2-DIOL
AB0012754
AB01275441_02
AB01275441-01
AC-791
AC1NFJIT
AKOS015902328
AN-2762
API0004441
AS-7085
AX8154334
BC215342
BDBM50108877
BG0651
BIDD:GT0032
BRD-K10852020-001-01-1
C-17206
C07949
C14H11NO5
CAS-134308-13-7
CC-35089
CCG-221217
CCRIS 7904
CHEBI:63630
CHEMBL1324
CIF6334OLY
CS-1173
CTK8E7392
D00786
D0Y7PG
DB-013561
DB00323
DR000888
DSSTox_CID_3685
DSSTox_GSID_23685
DSSTox_RID_77146
DTXSID3023685
EBD47899
FT-0082597
FT-0631149
GTPL6646
HMS2089K14
HMS3652M17
HY-17406
I14-13303
InChI=1/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H
KB-01394
KS-00000XJL
KS-1314
LS-91226
Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-
Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)
Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-
MFCD00866569
MIQPIUSUKVNLNT-UHFFFAOYSA-N
MLS006012044
MolPort-003-850-570
NCGC00181767-01
NCGC00181767-02
NCGC00181767-03
NCGC00255188-01
OR214715
Q-201840
Ro 40-7592
Ro-40-7592
Ro-407592
ro40-7592
Roche brand of tolcapone
RT-016044
s4021
SCHEMBL33869
SMR001614567
SR-05000001444
SR-05000001444-1
Talcapone
Tasmar (TN)
TCW
Tolcapon
Tolcapona
Tolcapone
Tolcapone (JAN/USAN/INN)
Tolcapone [USAN:INN]
Tolcapone, >=98% (HPLC)
Tolcapone, United States Pharmacopeia (USP) Reference Standard
tolcaponetolcapone
Tolcaponum
Tox21_112963
Tox21_112963_1
Tox21_302414
UNII-CIF6334OLY
W-5146
ZINC35342789

US Patents and Regulatory Information for TASMAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms Llc TASMAR tolcapone TABLET;ORAL 020697-001 Jan 29, 1998 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms Llc TASMAR tolcapone TABLET;ORAL 020697-002 Jan 29, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for TASMAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms Llc TASMAR tolcapone TABLET;ORAL 020697-002 Jan 29, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms Llc TASMAR tolcapone TABLET;ORAL 020697-001 Jan 29, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms Llc TASMAR tolcapone TABLET;ORAL 020697-002 Jan 29, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms Llc TASMAR tolcapone TABLET;ORAL 020697-001 Jan 29, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Baxter
US Department of Justice
Argus Health
Julphar
Cipla
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.